CCRN
Income statement / Annual
Last year (2023), Cross Country Healthcare, Inc.'s total revenue was $2.02 B,
a decrease of 28.04% from the previous year.
In 2023, Cross Country Healthcare, Inc.'s net income was $72.63 M.
See Cross Country Healthcare, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$2.02 B
|
$2.81 B
|
$1.68 B
|
$836.42 M
|
$822.22 M
|
$816.48 M
|
$865.05 M
|
$833.54 M
|
$767.42 M
|
$617.83 M
|
| Cost of Revenue |
$1.59 B |
$2.18 B |
$1.30 B |
$633.69 M |
$618.22 M |
$606.92 M |
$636.46 M |
$611.80 M |
$570.06 M |
$460.02 M |
| Gross Profit |
$432.06 M |
$627.69 M |
$375.00 M |
$202.73 M |
$204.01 M |
$209.56 M |
$228.59 M |
$221.74 M |
$197.37 M |
$157.80 M |
| Gross Profit Ratio |
0.21 |
0.22 |
0.22 |
0.24 |
0.25 |
0.26 |
0.26 |
0.27 |
0.26 |
0.26 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$303.45 M
|
$308.11 M
|
$205.79 M
|
$167.61 M
|
$174.06 M
|
$180.23 M
|
$187.44 M
|
$179.82 M
|
$161.28 M
|
$141.02 M
|
| Selling & Marketing
Expenses |
$11.50 M
|
$16.10 M
|
$9.50 M
|
$6.20 M
|
$7.90 M
|
$6.70 M
|
$7.60 M
|
$10.20 M
|
$4.90 M
|
$4.10 M
|
| Selling, General &
Administrative Expenses |
$314.95 M
|
$324.21 M
|
$215.29 M
|
$173.81 M
|
$181.96 M
|
$180.23 M
|
$187.44 M
|
$179.82 M
|
$161.28 M
|
$141.02 M
|
| Other Expenses |
-$2,000.00 |
$12.58 M |
$9.85 M |
$12.67 M |
$14.08 M |
$418,000.00 |
$155,000.00 |
$230,000.00 |
$306,000.00 |
$30,000.00 |
| Operating Expenses |
$314.95 M |
$336.79 M |
$225.14 M |
$186.48 M |
$196.03 M |
$192.01 M |
$197.61 M |
$189.00 M |
$169.34 M |
$148.46 M |
| Cost And Expenses |
$1.90 B |
$2.52 B |
$1.53 B |
$820.17 M |
$814.25 M |
$798.93 M |
$834.07 M |
$800.80 M |
$739.40 M |
$608.48 M |
| Interest Income |
$0.00 |
$14.39 M |
$6.87 M |
$2.89 M |
$5.31 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$8.09 M |
$14.39 M |
$6.87 M |
$2.89 M |
$5.31 M |
$5.65 M |
$4.21 M |
$6.11 M |
$6.81 M |
$4.16 M |
| Depreciation &
Amortization |
$18.35 M
|
$14.43 M
|
$12.28 M
|
$16.22 M
|
$14.08 M
|
$11.78 M
|
$10.17 M
|
$9.18 M
|
$8.07 M
|
$7.44 M
|
| EBITDA |
$135.46 M
|
$304.81 M
|
$160.48 M
|
$28.64 M
|
$22.12 M
|
$29.75 M
|
$41.31 M
|
$42.15 M
|
$36.40 M
|
$16.82 M
|
| EBITDA Ratio |
0.07 |
0.11 |
0.1 |
0.03 |
0.03 |
0.04 |
0.05 |
0.05 |
0.05 |
0.03 |
| Operating Income Ratio
|
0.06
|
0.1
|
0.08
|
0.02
|
0.01
|
-0.02
|
0.01
|
0.01
|
0.03
|
-0.02
|
| Total Other
Income/Expenses Net |
-$14.22 M
|
-$16.78 M
|
-$6.10 M
|
-$28.30 M
|
-$32.25 M
|
-$30.09 M
|
-$22.46 M
|
-$22.08 M
|
-$17.05 M
|
-$36.50 M
|
| Income Before Tax |
$102.89 M |
$256.33 M |
$133.21 M |
-$12.33 M |
-$24.21 M |
-$18.20 M |
$4.30 M |
$4.55 M |
$4.16 M |
-$31.32 M |
| Income Before Tax Ratio
|
0.05
|
0.09
|
0.08
|
-0.01
|
-0.03
|
-0.02
|
0
|
0.01
|
0.01
|
-0.05
|
| Income Tax Expense |
$30.26 M |
$67.86 M |
$1.21 M |
-$188,000.00 |
$31.73 M |
-$2.48 M |
-$34.50 M |
-$4.19 M |
-$794,000.00 |
$216,000.00 |
| Net Income |
$72.63 M |
$188.46 M |
$132.00 M |
-$12.14 M |
-$55.94 M |
-$16.95 M |
$37.51 M |
$7.97 M |
$4.42 M |
-$31.78 M |
| Net Income Ratio |
0.04 |
0.07 |
0.08 |
-0.01 |
-0.07 |
-0.02 |
0.04 |
0.01 |
0.01 |
-0.05 |
| EPS |
2.07 |
5.09 |
3.6 |
-0.34 |
-1.56 |
-0.48 |
1.07 |
0.25 |
0.14 |
-1.02 |
| EPS Diluted |
2.05 |
5.02 |
3.53 |
-0.34 |
-1.56 |
-0.48 |
1.01 |
0.15 |
0.14 |
-1.02 |
| Weighted Average Shares
Out |
$35.16 M
|
$37.01 M
|
$36.69 M
|
$36.09 M
|
$35.82 M
|
$35.31 M
|
$35.02 M
|
$32.13 M
|
$31.51 M
|
$31.16 M
|
| Weighted Average Shares
Out Diluted |
$35.48 M
|
$37.54 M
|
$37.39 M
|
$36.09 M
|
$35.82 M
|
$35.66 M
|
$36.17 M
|
$36.25 M
|
$32.16 M
|
$31.19 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
